Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|pharmaceutical industry · TRADE|marketing|marketing|market approval
    cothromaíocht idir rioscaí agus tairbhí Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    cothromaíocht sochair-riosca Reference "Rialachán (AE) 2019/6 maidir le táirgí íocshláinte tréidliachta agus lena n-aisghairtear Treoir 2001/82/CE, CELEX:32019R0006/GA Faomhadh an téarma seo mar chuid de Thionscadal Lex"
    ga
    Risiko-Nutzen-Bilanz | Nutzen-Risiko-Profil | Nutzen-Risiko-Verhältnis
    de
    benefit-risk balance | risk-benefit balance | risk/benefit balance
    en
    Definition evaluation, carried out during the authorisation procedure, of the positive therapeutic effects of the medicinal product in relation to any risk relating to the quality, safety or efficacy of the medicinal product as regards patients' health or public health Reference "COM-EN, based on:Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use"
    rapport bénéfice/risque | rapport bénéfices/risques
    fr
    Definition évaluation des effets thérapeutiques positifs du médicament au regard du risque Reference "Directive 2001/83/CE instituant un code communautaire relatif aux médicaments à usage humain (version consoliée), http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2001L0083:20110721:FR:HTML [8.10.2012]"